Pulse Biosciences appoints Jon Skinner as CFO effective Feb 3, 2025

PULSE BIOSCIENCES, INC.

Jon Skinner appointed CFO effective Feb 3, 2025; previously VP at Copeland and Imperative Care.
Annual base salary $400,000, target bonus 50% of salary, sign-on bonus up to $56,000.
Granted option for 300,000 shares at $20.93 (closing on Jan 31, 2025) with four-year vesting.
Half of options vest time-based over 4 years; half vest based on market cap and revenue milestones.
Milestones include market caps of $2B to $5B and GAAP product revenues of $8M to $175M.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jon Skinner

Chief Financial Officer

PLSE · PULSE BIOSCIENCES, INC.

Effective: 2025-02-03
Filed: February 4, 2025, 6:59 PM ET

Pulse Biosciences, Inc. (the “Company”) has appointed Jon Skinner as Chief Financial Officer of the Company, effective as of February 3, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jon Skinner was appointed as Chief Financial Officer at PULSE BIOSCIENCES, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Pulse Biosciences, Inc. (the “Company”) has appointed Jon Skinner as Chief Financial Officer of the Company, effective as of February 3, 2025

View on SEC.gov

PULSE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-002664

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.